首页|血小板与淋巴细胞比值与胃癌患者新辅助化疗短期预后的关系

血小板与淋巴细胞比值与胃癌患者新辅助化疗短期预后的关系

扫码查看
目的:分析血小板与淋巴细胞比值(PLR)与胃癌患者新辅助化疗短期预后的关系.方法:选取2019年2月—2022年12月在武陟县人民医院就诊的100例胃癌患者,对比胃癌患者化疗前后的血小板计数(PLT)、淋巴细胞(LYM)及PLR水平.根据化疗效果,将患者分为预后良好组和预后不良组,对比两组患者入院时的基线资料及PLT、LYM及PLR水平;采用ROC曲线分析PLR预测胃癌患者新辅助化疗短期预后的价值.结果:化疗后,胃癌患者的PLT、PLR水平明显低于化疗前,LYM明显高于化疗前,差异有统计学意义(t=8.655、16.439、6.477,P<0.05).100例晚期胃癌患者均完成3个周期的新辅助化疗,其中完全缓解(CR)1例(1.00%),部分缓解(PR)33例(33.00%),稳定(SD)47例(47.00%),进展(PD)19例(19.00%).预后良好组的多项指标与预后不良组相比,差异无统计学意义(P>0.05);而两组患者的TNM分期、PLT、LYM及NLR水平相比,差异有统计学意义(x2=9.833,t=7.359、5.299、13.055,P<0.05).ROC曲线结果显示,PLR的曲线下面积为0.876,灵敏度为91.2%,特异度为83.4%(95%CI:0.821~0.945),最佳截断值约为153.7(P<0.05),表示PLR可作为评价胃癌患者新辅助化疗短期预后的有效检测指标.结论:经过新辅助化疗后,胃癌患者的PLR水平明显降低;且PLR呈高表达不利于患者预后,因此,可在早期检测PLR以预测患者的预后不良风险.
Relationship Between Platelet to Lymphocyte Ratio and Short-term Prognosis of Patients with Gastric Cancer Treated with Neoadjuvant Chemotherapy
Objective:To analyze the relationship between platelet to lymphocyte ratio and short-term prognosis of patients with gastric cancer treated with neoadjuvant chemotherapy.Methods:A total of 100 patients with gastric cancer who were treated in the hospital from February 2019 to December 2022 were selected.The platelet count(PLT),lymphocyte(LYM)and PLR levels of gastric cancer patients before and after chemotherapy were compared.According to the effect of chemotherapy,the patients were divided into good prognosis group and poor prognosis group.The baseline data and PLT,LYM and PLR levels at admission were compared between the two groups.Receiver operating characteristic(ROC)curve was used to analyze the value of PLR in predicting the short-term prognosis of gastric cancer patients after neoadjuvant chemotherapy.Results:After chemotherapy,PLT and PLR levels of gastric cancer patients were significantly lower than those before chemotherapy,LYM was significantly higher than that before chemotherapy(t=8.655,16.439,6.477;P<0.05).A total of 100 patients with advanced gastric cancer completed 3 cycles of neoadjuvant chemotherapy,including 1 case(1.00%)of complete remission(CR),33 cases(33.00%)of partial remission(PR),47 cases(47.00%)of stable disease(SD),and 19 cases(19.00%)of progressive disease(PD).There were no significant differences in many indicators between the good prognosis group and the poor prognosis group(P>0.05).There were significant differences in TNM stage,PLT,LYM and NLR levels between the two groups(x2=9.833,t=7.359,5.299,13.055;P<0.05).The results of ROC curve showed that the area under the curve of PLR was 0.876,the sensitivity was 91.2%,the specificity was 83.4%(95%CI:0.821~0.945),and the best cut-off value was about 153.7(P<0.05),indicating that PLR could be used as an effective detection index to evaluate the short-term prognosis of gastric cancer patients after neoadjuvant chemotherapy.Conclusion:After neoadjuvant chemotherapy,the PLR level of patients with gastric cancer decreased significantly.The high expression of PLR is not conducive to the prognosis of patients.Therefore,PLR can be detected at early stage to predict the risk of poor prognosis of patients.

Platelet to lymphocyte ratioGastric cancerNeoadjuvant chemotherapyPrognosis

赵利娟、梁彬、张文文

展开 >

焦作市武陟县人民医院消化内科,河南 焦作 454950

血小板与淋巴细胞比值 胃癌 新辅助化疗 预后

2024

黑龙江医学
中华医学会黑龙江分会

黑龙江医学

影响因子:0.714
ISSN:1004-5775
年,卷(期):2024.48(10)
  • 17